Mollica, V.; Rizzo, A.; Rosellini, M.; Marchetti, A.; Ricci, A.D.; Cimadamore, A.; Scarpelli, M.; Bonucci, C.; Andrini, E.; Errani, C.;
et al. Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art. Cancers 2021, 13, 546.
https://doi.org/10.3390/cancers13030546
AMA Style
Mollica V, Rizzo A, Rosellini M, Marchetti A, Ricci AD, Cimadamore A, Scarpelli M, Bonucci C, Andrini E, Errani C,
et al. Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art. Cancers. 2021; 13(3):546.
https://doi.org/10.3390/cancers13030546
Chicago/Turabian Style
Mollica, Veronica, Alessandro Rizzo, Matteo Rosellini, Andrea Marchetti, Angela Dalia Ricci, Alessia Cimadamore, Marina Scarpelli, Chiara Bonucci, Elisa Andrini, Costantino Errani,
and et al. 2021. "Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art" Cancers 13, no. 3: 546.
https://doi.org/10.3390/cancers13030546
APA Style
Mollica, V., Rizzo, A., Rosellini, M., Marchetti, A., Ricci, A. D., Cimadamore, A., Scarpelli, M., Bonucci, C., Andrini, E., Errani, C., Santoni, M., Montironi, R., & Massari, F.
(2021). Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art. Cancers, 13(3), 546.
https://doi.org/10.3390/cancers13030546
